Gateway to Translation Webinar: eg technology
The “Gateway to Translation” (G2T) webinar series is a joint initiative between the University of Cambridge (Cambridge Academy of Therapeutic Sciences, CATS) and the University of Manchester (Translation Manchester).
The aim of these monthly webinars is to stimulate the translation of research into the clinics by educating academics about trends, technologies and research in the commercial sphere and by facilitating collaborations between academia and the medtech, biotech and pharma industry sectors. Recordings from previous webinars are available here.
David Warwick – Director at eg technology ltd
In the January webinar of this series our guest speaker was David Warwick (Director at eg technology Ltd). David shared his insights on “Medical devices from initial idea to developing a prototype: practical considerations“.
eg technology is a product design, engineering & development specialist company based in Cambridge, UK, providing an integrated solution for innovators requiring the expertise to bridge the gap between their idea and a market-ready product. eg works with companies of all sizes, from blue-chip to start-up, on a range of projects to deliver inspiring, marketable and industry-transforming products across MedTech, Lab/BioTech, VetCare, CleanTech, AgriTech, Consumer and Food/Drink Sectors.
Topic: “Medical devices from initial idea to developing a prototype: practical considerations“
Guest Speaker: David Warwick, Director at eg technology Ltd.
The webinar was chaired by Dr Harry Bulstrode, Group Leader at the Cambridge Stem Cell Institute and Honorary Consultant Neurosurgeon at Addenbrooke’s Hospital.
Click to learn more about the speaker
David is a director at eg technology with extensive experience in the compilation of technical files and regulatory requirements for software development of CE marked and FDA approved medical devices. His expertise includes the application of standards, design specifications and testing at all stages of the product development cycle. David has an overall responsibility for the management of new and existing client accounts. He works closely with the senior management team to evaluate business operations and strategy for the consistent business development and growth of eg.
David has been with eg technology since 2008 and was appointed as a director of the company in 2019. Prior to this, David forged a career in software engineering and product development in the MedTech and BioTech sectors. He holds an MBA and Diploma in Economics from the Open University following his degree in Computer System Engineering from the University of Warwick.
Watch a recording from the event below:
Contact Us
Email:
0 Comments